Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study
Clinical trial NCT03563053 · TERMINATED
Trial details
- NCT number
- NCT03563053
- Sponsor
- Quince Therapeutics S.p.A.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2022-09-02
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.